Access to diagnostic tests and essential medicines for cardiovascular diseases and diabetes care: cost, availability and affordability in the West Region of Cameroon
Posted on 26 November 2015
SUMMARY of FINDINGS
In Cameroon, the cost of primary and secondary prevention of cardiovascular disease is largely unaffordable. For example:
- The cost of treating a patient with ischemic heart disease with a drug combination comprising a beta blocker (atenolol), angiotensin converting enzyme inhibitor (Captopril) statin (Simvastatin) and acetyl salicylic acid is at least 41 days of wages per month of the lowest paid government worker.
- The cost of primary prevention in patient with cardiovascular risk > 20% varies between 32 to 35 days of wages per month of the lowest paid government worker.
To assess the prices, availability and affordability of selected routine tests and common essential medicines for CVD and diabetes in Cameroon
20 medicines used to treat cardiovascular diseases (CVD) and diabetes were selected for the survey.
Diagnostic tests for CVD and diabetes included in the minimal World Health Organization (WHO) workup and other tests that were considered relevant for assessment and management of cardiovascular risk as recommended by WHO.
Year of the Survey
Cardiovascular diseases and diabetes
Cameroon (West Region of Cameroon)
SOURCE of data
Survey performed in 6 urban and 5 rural outlets in west region of Cameroon. In total, 2 private outlets (one in the formal sector and one in the informal circuit) and 9 public outlets were investigated. Date were collected in all sites during one week period in 2012 using a preconceived questionnaire based on the standardized method for surveying medicines prices, availability, affordability and price components in low and middle incomes countries developed by WHO and Health Action International.
TYPE of COST
Prices of drugs and test directly charge to clients.
In the absence of social security system in Cameroon, medications and tests covered in the current study were paid from out-of-pocket money.
SOURCE of COST
Community pharmacies, hospital pharmacies
FCFA, US dollar
Jingi AM, Noubiap JJ, Ewane Onana A, Nansseu JR, Wang B, Kingue S, Kengne AP. Access to diagnostic tests and essential medicines for cardiovascular diseases and diabetes care: cost, availability and affordability in the West Region of Cameroon. PLoS One. 2014 Nov 4;9(11):e111812.